Resources

In this blog, the BIA's Senior Policy and Public Affairs Manager, Dr Emma Lawrence, discusses the life science implications of Lord Darzi's review.

The political party conference season is in full swing, and the BIA is out in force in Liverpool for the Labour Party conference this week. I'm heartened to see the focus in ministerial speeches and the fringe on topics close to our hearts. Read on for updates on the Lib Dem conference, West Streeting speech and Invest in Women Taskforce.

With a little over eight weeks to go to London Life Sciences Week (LLSW), we are launching a new website - lifesciencesweek.london - and lifting the lid on all that is happening to make the UK the place to be for life sciences this November. Continue reading for updates on NHS, £12 million Innovate UK funding, and more!

Steve Bates OBE, CEO of BIA, responds to BVCA’s recommendations on increasing pensions investment in fast-growing businesses.

This week I’ve been engaging with City and Government figures seeking to develop practical measures enabling UK life science to deliver our full growth potential. The key autumn dates remain the Government’s International Investment Summit on 14 October and the Budget on 30 October but the debate about what should be in this is already well underway.

It’s a back-to-school feel with a bang for me this week as the landscape of the Association’s work til Christmas comes into sharp focus. Read on for our proposals for a sector-by-sector approach to analyse the effectiveness of R&D tax reliefs, turning health into economic growth, pandemics and more!

The Chancellor’s Budget on 30 October is an opportunity to end short-termism, cut waste, and attract long-term investment to the UK economy with a sector-targeted R&D tax relief policy. However, changes should not be rushed and must be based on the best economic evidence.

Following on from our roundtable in April of this year, Amrita Saha (left) and Anabel Marin (right) from the Institute of Development Studies (IDS) have written a blog discuss the lessons to be learnt from the UK's Covid-19 Vaccine Response. ​

This special summer newscast brings you up to date with the new UK government's engagement with life sciences, snapshots latest financing figures and showcases new BIA capacity through our new online presence.

I will watch the General Election this Thursday with great interest, like the rest of the country, and update you on the new ministers and members of Parliament next week. You can access the policy backgrounds of the main parties and view our webinar on what the campaign has taught us about what our sector should expect from the new parliament and government.

With fewer than twenty days to go and the manifestoes of the main parties now published, the BIA policy team pick apart what each party is pledging for the life science sector.

UK General Election and what it might mean for the industry, including Labour's pledges on Brexit and business taxes. Upcoming events including the Cambridge Wide Open Day and the Life Science Leadership Summit. UK tech companies pitching at the London Stock Exchange and Amber Therapeutics securing $100 million in funding.

MSD Merck acquire UK biotech EyeBio for $1.3 billion upfront, ASCO and BIO conference week and the UK General election campaign produces little news for the life science sector.

The UK general election has been called for Thursday, 4 July. In practical terms, this means the end of the legislative pathway for many proposals as Parliament shuts down. It also means the policy-making function of the civil service machine slows to a crawl and with it the cancellation of planned formal meetings of government and industry, like the Life Science Council in June. Keep reading for updates on our general election webinars and UK events at BIO 2024.

The UK General Election has been called for Thursday, 4 July. In practical terms, this means the end of the legislative pathway for many proposals as Parliament shuts down. Keep reading for updates on our general election webinars and UK events at BIO 2024.